Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond.
Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond.
复制标题
DOI：
10.1161/jaha.120.017787
复制
发表时间：
2020-10-20
影响因子：
5.4
通讯作者：
Jneid H
中科院分区：
文献类型：
--
作者：
Addison D;Campbell CM;Guha A;Ghosh AK;Dent SF;Jneid H
2019冠状病毒病（COVID-19）已成为全球流行病和公共卫生危机。越来越多的间歇性传染病暴发极大地影响了广大人群的护理。在过去的20年里，癌症存活率迅速增加，每年有超过40万新的幸存者。在癌症治疗期间或之后，患者越来越常见的心血管疾病导致了心血管肿瘤学领域的快速发展，其任务是识别，治疗和预防该人群中出现的各种形式的心血管疾病。本综述评估了大流行对心脏肿瘤学实践和研究的影响。对这一人群中共病和临床结局之间关系的不断发展的理解进行了评估。在大流行的推动下，心脏肿瘤学可以在肿瘤护理期间对心脏筛查、监测和干预进行审慎的改变。作为两个专业的桥梁，考虑到在癌症和心血管方面的经验教训，可以为正在进行的治疗工作提供重要信息。此外，还应考虑开发专注于了解和优化这些患者结局的多中心登记研究。总之，这些见解可能会为COVID-19大流行未来阶段及以后的心脏肿瘤患者护理策略提供重要信息。
Coronavirus disease 2019 (COVID‐19) has emerged as a global pandemic and public health crisis. Increasing waves of intermittent infectious outbreaks have dramatically influenced care among broad populations. Over the past 2 decades, there has been a rapid increase in cancer survival, with >400 000 new survivors each year. The increasingly common presence of cardiovascular disease in patients during or after cancer treatment led to the rapid growth of the field of cardio‐oncology with a mandate of identifying, treating, and preventing the various forms of cardiovascular disease seen among this population. This review evaluates the implications of the pandemic on the practice and study of cardio‐oncology. The evolving understanding of the relationship between comorbid disease and clinical outcomes among this population is assessed. With the impetus of the pandemic, cardio‐oncology can be deliberate in embracing changes to cardiac screening, monitoring, and intervention during oncology care. Bridging 2 specialties, consideration of the lessons learned in cancer and cardiovascular may pivotally inform ongoing therapeutic efforts. Further, the development of multicenter registries focused on understanding and optimizing outcomes among these patients should be considered. Together, these insights may critically inform strategies for the care of cardio‐oncology patients in future phases of the COVID‐19 pandemic and beyond.